ClinicalTrials.Veeva

Menu

Altered Neural Pain Empathic Reactivity in NSSI Adolescents

U

University of Electronic Science and Technology of China

Status

Enrolling

Conditions

Nonsuicidal Self Injury
Pain Empathy

Study type

Observational

Funder types

Other

Identifiers

NCT05968313
BAM_lab_NSSI_02

Details and patient eligibility

About

Nonsuicidal self-injury (NSSI) is defined as direct, deliberate bodily harm without suicidal intention. In recent years, growing evidence suggests that NSSI has become a worldwide public health issue. People with NSSI behaviors, especially adolescents, commonly exhibit emotion-related and interpersonal problems. Pain empathy represents an essential basal domain of socio-emotional processing and refers to the ability to empathize, connect and share with others' pain. However, altered empathic processing has not been systematically examined in adolescents with NSSI. To this end, the current functional magnetic resonance imaging (fMRI) study will recruit one group of NSSI adolescents (n=40) and one healthy control (HC) group (n=40), to compare their neural activity regarding pain empathy processing, which is measured by blood oxygenation level-dependent (BOLD) fMRI. The investigators included conditions of physical pain empathy (stimuli depicting noxious stimulation to the limbs) and affective pain empathy (stimuli depicting faces expressing pain) as well as corresponding control stimuli. The investigators hypothesize that compared to HC, NSSI adolescents show increased empathic reactivity to physical pain stimuli in salience and arousal related brain regions but decreased empathic reactivity to affective pain empathic stimuli.

Enrollment

80 estimated patients

Sex

All

Ages

15 to 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 15-18 years
  • right-handed
  • normal or corrected normal visual acuity
  • meet the proposed DSM-5 frequency criteria (e.g., ≥5 days of NSSI behaviors in the past year)

Exclusion criteria

  • diagnosis of borderline personality disorder, major depressive disorder, other
  • psychiatric disorders, etc.
  • high suicidal risk
  • recent use of medications that can affect neural activity
  • have received or are receiving Dialectical Behavior Therapy (DBT) other treatment for emotional problems within the past 6 months
  • have a contraindication to MRI scanning (e.g., metal implants, claustrophobia or other conditions that make them inappropriate for MRI scanning)

Trial design

80 participants in 2 patient groups

NSSI
HC

Trial contacts and locations

1

Loading...

Central trial contact

Benjamin Becker

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems